Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 2
1978 2
1980 1
1981 1
1982 8
1983 5
1985 6
1986 5
1987 3
1988 7
1989 7
1990 9
1991 5
1992 6
1993 15
1994 7
1995 12
1996 10
1997 9
1998 16
1999 11
2000 18
2001 11
2002 16
2003 18
2004 18
2005 13
2006 16
2007 17
2008 10
2009 15
2010 16
2011 14
2012 11
2013 12
2014 16
2015 16
2016 19
2017 18
2018 4
2019 5
2020 8
2021 5
2022 7
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Abnormal HDL cholesterol concentration"
Page 1
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease.
DiNicolantonio JJ, Lucan SC, O'Keefe JH. DiNicolantonio JJ, et al. Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):464-72. doi: 10.1016/j.pcad.2015.11.006. Epub 2015 Nov 14. Prog Cardiovasc Dis. 2016. PMID: 26586275 Free PMC article. Review.
However, TC is only modestly associated with CHD, and more important than the total level of cholesterol in the blood may be the number and size of low-density lipoprotein (LDL) particles that contain it. ...Such replacement leads to changes in LDL, high-density lipoprotei …
However, TC is only modestly associated with CHD, and more important than the total level of cholesterol in the blood may be the numb …
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, Watts GF, Sypniewska G, Wiklund O, Borén J, Chapman MJ, Cobbaert C, Descamps OS, von Eckardstein A, Kamstrup PR, Pulkki K, Kronenberg F, Remaley AT, Rifai N, Ros E, Langlois M; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) joint consensus initiative. Nordestgaard BG, et al. Eur Heart J. 2016 Jul 1;37(25):1944-58. doi: 10.1093/eurheartj/ehw152. Epub 2016 Apr 26. Eur Heart J. 2016. PMID: 27122601 Free PMC article.
METHODS AND RESULTS: Extensive observational data, in which random non-fasting lipid profiles have been compared with those determined under fasting conditions, indicate that the maximal mean changes at 1-6 h after habitual meals are not clinically significant [+0.3 mmol/L …
METHODS AND RESULTS: Extensive observational data, in which random non-fasting lipid profiles have been compared with those determine …
PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M, Luque-Ramírez M, Nattero-Chávez L, Escobar-Morreale HF. Millán-de-Meer M, et al. Hum Reprod Update. 2023 Nov 2;29(6):741-772. doi: 10.1093/humupd/dmad015. Hum Reprod Update. 2023. PMID: 37353908
Women with PCOS showed increased BMI (SMD 0.57 (0.32, 0.75)), waist circumference (SMD 0.64 (0.42, 0.86)), and waist-to-hip ratio (SMD 0.38 (0.14, 0.61)) together with increased homeostasis model assessment of insulin resistance (SMD 0.56 (0.27, 0.84)), fasting insulin (SMD 0.61 …
Women with PCOS showed increased BMI (SMD 0.57 (0.32, 0.75)), waist circumference (SMD 0.64 (0.42, 0.86)), and waist-to-hip ratio (SMD 0.38 …
HDL abnormalities in type 2 diabetes: Clinical implications.
Martagon AJ, Zubirán R, González-Arellanes R, Praget-Bracamontes S, Rivera-Alcántara JA, Aguilar-Salinas CA. Martagon AJ, et al. Atherosclerosis. 2024 Jul;394:117213. doi: 10.1016/j.atherosclerosis.2023.117213. Epub 2023 Aug 3. Atherosclerosis. 2024. PMID: 37580206 Review.
Atherosclerotic cardiovascular disease (ASCVD) represents the primary cause of mortality among patients with Type 2 Diabetes Mellitus (T2DM). In this population, High-Density Lipoprotein (HDL) particles exhibit abnormalities in number, composition, and function, cul …
Atherosclerotic cardiovascular disease (ASCVD) represents the primary cause of mortality among patients with Type 2 Diabetes Mellitus (T2DM) …
Dyslipidemia and oxidative stress in PCOS.
Macut D, Bjekić-Macut J, Savić-Radojević A. Macut D, et al. Front Horm Res. 2013;40:51-63. doi: 10.1159/000341683. Epub 2012 Oct 18. Front Horm Res. 2013. PMID: 24002405 Review.
Among cardiovascular risk factors, dyslipidemia is certainly the most persistent and highly prevalent. Predominant observation is an elevation of LDL cholesterol in all PCOS patients. Decreased concentrations of HDL cholesterol are found in obese PCOS …
Among cardiovascular risk factors, dyslipidemia is certainly the most persistent and highly prevalent. Predominant observation is an elevati …
Hyperlipidemia of chronic renal failure.
Kaysen GA. Kaysen GA. Blood Purif. 1994;12(1):60-7. doi: 10.1159/000170146. Blood Purif. 1994. PMID: 7986478 Review.
Plasma triglycerides are increased in the majority of patients with advanced renal failure but cholesterol is not. HDL cholesterol is reduced while LDL IDL and VLDL cholesterol is increased. Lecithin:cholesterol acyltransferase (LCAT), an enzyme …
Plasma triglycerides are increased in the majority of patients with advanced renal failure but cholesterol is not. HDL chol …
Androgens and coronary artery disease.
Wu FC, von Eckardstein A. Wu FC, et al. Endocr Rev. 2003 Apr;24(2):183-217. doi: 10.1210/er.2001-0025. Endocr Rev. 2003. PMID: 12700179 Review.
Hypoandrogenemia in men and hyperandrogenemia in women are associated with visceral obesity; insulin resistance; low high-density lipoprotein (HDL) cholesterol (HDL-C); and elevated triglycerides, low-density lipoprotein cholesterol, and plasminogen ac …
Hypoandrogenemia in men and hyperandrogenemia in women are associated with visceral obesity; insulin resistance; low high-density lipoprotei …
The Role of Dietary Cholesterol in Lipoprotein Metabolism and Related Metabolic Abnormalities: A Mini-review.
Kapourchali FR, Surendiran G, Goulet A, Moghadasian MH. Kapourchali FR, et al. Crit Rev Food Sci Nutr. 2016 Oct 25;56(14):2408-15. doi: 10.1080/10408398.2013.842887. Crit Rev Food Sci Nutr. 2016. PMID: 26055276 Review.
However, diet-increased serum cholesterol levels do not increase the low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, nor do they decrease the size of LDL particles or HDL cholesterol levels. Elevated levels of LDL …
However, diet-increased serum cholesterol levels do not increase the low-density lipoprotein/high-density lipoprotein (LDL/HDL …
Treatment approaches for diabetes and dyslipidemia.
Wu M, Lyons TJ. Wu M, et al. Horm Res Paediatr. 2011;76 Suppl 1(Suppl 1):76-80. doi: 10.1159/000329180. Epub 2011 Jul 21. Horm Res Paediatr. 2011. PMID: 21778754 Free PMC article. Review.
BACKGROUND: Dyslipidemia is an important risk factor for cardiovascular complications in persons with diabetes. Low-density lipoprotein-cholesterol (LDL-C) is the 'cornerstone' for assessment of lipoprotein-associated risk. However, LDL-C levels do not reflect the classic …
BACKGROUND: Dyslipidemia is an important risk factor for cardiovascular complications in persons with diabetes. Low-density lipoprotein-c …
Fenofibrate: treatment of hyperlipidemia and beyond.
Rosenson RS. Rosenson RS. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1319-30. doi: 10.1586/14779072.6.10.1319. Expert Rev Cardiovasc Ther. 2008. PMID: 19018684 Review.
Treatment with fenofibrate lowers triglycerides, raises HDL-cholesterol and decreases concentrations of small LDL-cholesterol particles and apolipoprotein B. Fenofibrate is particularly effective for reducing postprandial VLDL and LDL particle conce …
Treatment with fenofibrate lowers triglycerides, raises HDL-cholesterol and decreases concentrations of small LDL-ch …
428 results